Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Obama Medicaid Rebate Provisions Make Way Into Finance Cmte. Options

Executive Summary

The Senate Finance Committee is looking to the pharmaceutical industry to contribute to paying for health care reform in the form of adjustments to Medicaid rebates and the introduction of means testing in Medicare Part D
Advertisement

Related Content

HELP Health Reform Bill On Fast Track With Gaps To Fill; Dodd Takes Reins
HELP Health Reform Bill On Fast Track With Gaps To Fill; Dodd Takes Reins
Health Coalition’s Cost-Cutting Pledge Needs Five-Year Target – Orszag
Baucus Flags Key Aspects Of Health Reform Bill To Set In Statute
Pharma Cost-Saving Options Take Backseat In Senate Reform Roundtable
Medicaid Eligibility Expansion Could Cost $500 Bil. Over 10 Years – Hatch
Senate Options Include Barring CER’s “Fast Track” To Coverage
More Rebates For More Coverage: Budget Seeks Medicaid Rx Rebate Of 22%
More Rebates For More Coverage: Budget Seeks Medicaid Rx Rebate Of 22%
Increasing Medicaid Rebate Could Lower Deficit By Over $7 Billion, CBO Says

Topics

Advertisement
UsernamePublicRestriction

Register

PS051100

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel